Keyphrases
Bone Alkaline Phosphatase
100%
N-telopeptide
100%
Hormone-sensitive Prostate Cancer
100%
Bone Metabolism Markers
100%
Overall Survival
42%
Multivariate Model
42%
Bone Metastasis
28%
Specific Marker
28%
Osteoclast Activity
28%
Lactate Dehydrogenase
28%
Hemoglobin
28%
Prostate-specific Antigen
28%
Osteoblast Functions
28%
Surgical Castration
28%
Analgesic Use
28%
Zoledronic Acid
14%
Multivariate Analysis
14%
Correlation Coefficient
14%
Disease Progression
14%
Confidence Interval
14%
Univariate Analysis
14%
Cox Proportional Hazards Model
14%
Albumin
14%
Prognostic Value
14%
Prognostic Factors
14%
Eastern Cooperative Oncology Group Performance Status (ECOG PS)
14%
Multicenter Randomized Controlled Trial
14%
Bone Disease
14%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
14%
Alkaline Phosphatase Level
14%
Baseline Covariates
14%
Prostate Cancer Metastasis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Telopeptide
100%
Alkaline Phosphatase
100%
Prostate Cancer
100%
Overall Survival
42%
Bone Metastasis
28%
Lactate Dehydrogenase
28%
Prostate Specific Antigen
28%
Analgesic Agent
28%
Metastasis
14%
Zoledronic Acid
14%
Disease Exacerbation
14%
Androgen
14%
Randomized Controlled Trial
14%
Bone Disease
14%
Biochemistry, Genetics and Molecular Biology
Alkaline Phosphatase
100%
Bone Remodeling
100%
Overall Survival
42%
Osteoclast Activity
28%
Lactate Dehydrogenase
28%
Osteoblast
28%
Prostate-Specific Antigen
28%
Multivariate Analysis
14%
Randomized Controlled Trial
14%